Evidence map›Paper›PMID 41184649›Full record

ReviewAAPS PharmSciTech2025

Dissolvable Microneedles with Their Design, Materials, and Limitations in Translation: a Technical Review.

Kirthana Gopal, Ramsha Khalid, Syed Mahmood

Abstract readReview
PubMed Publisher
In one paragraph

Review in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kirthana GopalDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Ramsha KhalidDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Syed MahmoodDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, 50603, Malaysia. syedmahmood@um.edu.my.ORCID http://orcid.org/0000-0002-9052-147X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dissolvable microneedles (DMNs) have emerged as a groundbreaking drug delivery platform, offering a minimally invasive alternative to conventional parenteral and oral administration while enabling precise, pain-free, and patient-friendly therapeutic delivery. This review provides a comprehensive technical overview of the design, materials, and translational challenges of DMN systems. We begin by examining critical design parameters, including microneedle geometry, array configuration, mechanical strength, and drug distribution, that directly influence insertion efficiency, structural integrity, and dissolution kinetics. The role of mathematical modeling in optimizing DMN performance is also explored, offering insights into drug diffusion, structural mechanics, and dissolution kinetics. The materials section highlights the diverse natural and synthetic polymers used in DMN fabrication, along with additives and stabilizers that modulate drug release, improve biocompatibility, and ensure formulation stability. Despite significant advances in preclinical research, the translation of DMNs into clinical and commercial applications remains hindered by several factors, including limitations in drug loading capacity, manufacturing scalability, dose precision, long-term storage stability, and regulatory complexity. We also explore user-centric challenges, including ease of administration, patient compliance, and cost-effectiveness. The final section discusses current strategies to address these barriers, including the use of smart and stimuli-responsive polymers, next-generation microfabrication techniques, and packaging innovations designed to enhance shelf life and user handling. Through this, we aim to provide a critical perspective on the design, materials, and future potential of DMN technology, charting a path toward its successful integration into mainstream healthcare systems.

Indexed as

Drug Delivery SystemsMicroinjectionsNeedlesAnimalsChemistry, PharmaceuticalDrug LiberationEquipment DesignHumansPolymersSolubilityPolymersclinical translationdissolvable microneedlelimitationspolymers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.